Expanding Access to Lung Cancer Clinical Trials by Reducing the Use of Restrictive Exclusion Criteria: Perspectives of a Multistakeholder Working Group.

Forde PM, Bonomi P, Shaw A, Blumenthal GM, Ferris A, Patel C, Melemed A, Basu Roy U, Ramamoorthy A, Liu Q, Burns T, Gainor JF, Lovly C, Piotrowska Z, Lehman J, Selig W
Clin Lung Cancer. 2020 21 (4): 295-307

PMID: 32201247 · DOI:10.1016/j.cllc.2020.02.008

MeSH Terms (6)

Clinical Trials as Topic Eligibility Determination Humans Lung Neoplasms Patient Selection Stakeholder Participation

Connections (2)

This publication is referenced by other Labnodes entities: